As of 2024-12-14, the Relative Valuation of Stoke Therapeutics Inc (STOK) is (44.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.06 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is -469.8%.
The range of the Relative Valuation is (41.25) - (38.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (41.25) - (38.26) | (44.60) |
| Upside | -442.0% - -417.3% | -469.8% |
| Date | P/E |
| 2024-11-20 | -5.81 |
| 2024-11-19 | -5.83 |
| 2024-11-18 | -5.97 |
| 2024-11-15 | -6.04 |
| 2024-11-14 | -6.99 |
| 2024-11-13 | -6.98 |
| 2024-11-12 | -6.84 |
| 2024-11-11 | -6.94 |
| 2024-11-08 | -6.97 |
| 2024-11-07 | -6.67 |
| 2024-11-06 | -6.66 |
| 2024-11-05 | -6.55 |
| 2024-11-04 | -6.58 |
| 2024-11-01 | -6.46 |
| 2024-10-31 | -6.21 |
| 2024-10-30 | -6.28 |
| 2024-10-29 | -6.23 |
| 2024-10-28 | -6.18 |
| 2024-10-25 | -5.98 |
| 2024-10-24 | -6.05 |
| 2024-10-23 | -6.06 |
| 2024-10-22 | -6.29 |
| 2024-10-21 | -6.32 |
| 2024-10-18 | -6.53 |
| 2024-10-17 | -6.67 |
| 2024-10-16 | -6.54 |
| 2024-10-15 | -6.37 |
| 2024-10-14 | -6.41 |
| 2024-10-11 | -5.95 |
| 2024-10-10 | -5.73 |
| 2024-10-09 | -6.00 |
| 2024-10-08 | -6.17 |
| 2024-10-07 | -5.73 |
| 2024-10-04 | -5.92 |
| 2024-10-03 | -5.93 |
| 2024-10-02 | -6.12 |
| 2024-10-01 | -6.21 |
| 2024-09-30 | -6.17 |
| 2024-09-27 | -6.15 |
| 2024-09-26 | -6.16 |
| 2024-09-25 | -6.41 |
| 2024-09-24 | -6.46 |
| 2024-09-23 | -6.67 |
| 2024-09-20 | -6.91 |
| 2024-09-19 | -7.60 |
| 2024-09-18 | -7.64 |
| 2024-09-17 | -7.59 |
| 2024-09-16 | -7.39 |
| 2024-09-13 | -7.27 |
| 2024-09-12 | -6.89 |